Autoimmunity in Retinitis Pigmentosa

NCT00433277 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

OTHER

Sponsor class

Conditions

Retinitis Pigmentosa

Interventions

DRUG: twice-daily dosage with 0.5% cyclosporine-A eyedrops

Sponsor

Semmelweis University